Capra Biosciences

About

Capra Biosciences is a biotechnology startup based in Sterling, VA, founded in 2020. The company focuses on the sustainable production of renewable chemicals that can replace petrochemicals. Using proprietary biofilm-based bioreactor technology, Capra converts waste carbon sources, such as food waste, into valuable hydrophobic molecules. The company aims to make the production of these chemicals cost-efficient and environmentally friendly, achieving significant savings in capital and operational expenditures. Capra's innovative continuous-flow bioreactor utilizes natural biofilms to enable efficient production of challenging chemicals. This technology minimizes the need for extensive downstream processing and supports low-emission generation from waste feedstocks. Capra's product lineup includes Bio-Retinol, a sustainable alternative for cosmetics, and salicylic acid, along with plans to develop high-performance lubricant base oils. The company is open to partnerships and has garnered support from investors like Closed Loop Partners and IndieBio/SOSV.